S

Sedia Biosciences Corp. / Calypte Biomedical

27 employees

Sedia Biosciences develops and sells medical diagnostic tests and monitoring tools used to battle against pandemics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
urine
Health Diagnostics
HIV incidence and assays to detect recent infections
diagnostic specimen collection devices
rapid point of care diagnostic assays
etc) test devices
alternative fluid (oral

Date founded

2009

Funding rounds raised

Total raised

$1.8M

from 2 investors over 2 rounds

S

Sedia Biosciences Corp. / Calypte Biomedical raised $1.8M on August 30, 2016

Investors: National Institutes of Health

S

Sedia Biosciences Corp. / Calypte Biomedical raised $200K on August 19, 2014

Investors: National Institutes of Health

FAQ